Quarterly report · Q2
2160.TEDINET S100ROIG
Period2023-01-01 → 2023-06-30
Filed2023-08-14
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥14.1bn | 2023-01-01 → 2023-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥9.9bn | 2023-04-01 → 2023-06-30d | Cons. | Revenue IFRS |
| Revenue | ¥17.4bn | 2022-01-01 → 2022-12-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥8.2bn | 2022-01-01 → 2022-06-30 | Cons. | Revenue IFRS |
| Revenue | ¥4.2bn | 2022-04-01 → 2022-06-30d | Cons. | Revenue IFRS |
| Operating income | ¥5.5bn | 2023-01-01 → 2023-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥5.1bn | 2023-04-01 → 2023-06-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥1.0bn | 2022-01-01 → 2022-06-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥526m | 2022-04-01 → 2022-06-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥5.1bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥5.2bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥768m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥790m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥443m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥1.7bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥1.7bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥389m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥676m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥325m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥4.0bn | 2023-01-01 → 2023-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥4.4bn | 2023-04-01 → 2023-06-30d | Cons. | Profit loss IFRS |
| Net income | −¥868m | 2022-01-01 → 2022-12-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥198m | 2022-01-01 → 2022-06-30 | Cons. | Profit loss IFRS |
| Net income | ¥126m | 2022-04-01 → 2022-06-30d | Cons. | Profit loss IFRS |
| Total assets | ¥45.1bn | at 2023-06-30 | Cons. | Assets IFRS |
| Total assets | ¥33.9bn | at 2022-12-31 | Cons. | Assets IFRS |
| Total assets | ¥35.3bn | at 2022-06-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥20.3bn | at 2023-06-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥14.1bn | at 2022-12-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥24.8bn | at 2023-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.8bn | at 2022-12-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥21.8bn | at 2022-06-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥19.3bn | at 2021-12-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥23.0bn | at 2023-06-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥21.0bn | at 2022-12-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥22.0bn | at 2022-06-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥14.1bn | at 2023-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥11.0bn | at 2022-12-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.5bn | at 2022-06-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥14.4bn | at 2021-12-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥872m | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥393m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥389m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥2.6bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥4.1bn | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥1.5bn | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥3.9bn | 2023-01-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥646m | 2022-01-01 → 2022-12-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | −¥267m | 2022-01-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥34.93 | 2023-01-01 → 2023-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥34.99 | 2023-04-01 → 2023-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥8.19 | 2022-01-01 → 2022-12-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥14.25 | 2022-01-01 → 2022-06-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥6.86 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥34.81 | 2023-01-01 → 2023-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥34.88 | 2023-04-01 → 2023-06-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥8.11 | 2022-01-01 → 2022-12-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥14.18 | 2022-01-01 → 2022-06-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥6.83 | 2022-04-01 → 2022-06-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 51.0% | at 2023-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 61.8% | at 2022-12-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 62.5% | at 2022-06-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 22
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-01-01 → 2023-06-30 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-01-01 → 2023-06-30 | −¥23m |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥1.4bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥1.3bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥23m |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥512m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2023-01-01 → 2023-06-30 | ¥12.8bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2023-01-01 → 2023-06-30 | ¥12.8bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2023-01-01 → 2023-06-30 | ¥5.0bn |
| —segment total | revenue | 2023-01-01 → 2023-06-30 | ¥14.1bn |
| —segment total | revenue external | 2023-01-01 → 2023-06-30 | ¥14.1bn |
| —segment total | revenue intersegment | 2023-01-01 → 2023-06-30 | ¥23m |
| —segment total | segment profit | 2023-01-01 → 2023-06-30 | ¥5.5bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥1.2bn |
| jpcrp040300-q2r_E05712-000Medical Devicereportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥526m |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | revenue external | 2022-01-01 → 2022-06-30 | ¥7.0bn |
| jpcrp040300-q2r_E05712-000Pharmaceuticalreportable segment | segment profit | 2022-01-01 → 2022-06-30 | ¥479m |
| —segment total | revenue | 2022-01-01 → 2022-06-30 | ¥8.2bn |
| —segment total | revenue external | 2022-01-01 → 2022-06-30 | ¥8.2bn |
| —segment total | segment profit | 2022-01-01 → 2022-06-30 | ¥1.0bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 670
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)太陽有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)新井 達哉 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)今川 義弘 | |
| Number of submission | FilingDateInstant | 1 | |
| Revenue IFRS (5-year summary) | Prior1YTDDuration | 8154817000 | JPY |
| Revenue IFRS (5-year summary) | CurrentYTDDuration | 14096545000 | JPY |
| Revenue IFRS (5-year summary) | Prior1YearDuration | 17418966000 | JPY |
| Revenue IFRS (5-year summary) | Prior1QuarterDuration | 4221327000 | JPY |
| Revenue IFRS (5-year summary) | CurrentQuarterDuration | 9890409000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YTDDuration | 790388000 | JPY |
| Profit loss before tax IFRS (5-year summary) | CurrentYTDDuration | 5117961000 | JPY |
| Profit loss before tax IFRS (5-year summary) | Prior1YearDuration | 767887000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YTDDuration | 197918000 | JPY |
| Profit loss IFRS (5-year summary) | CurrentYTDDuration | 4014074000 | JPY |
| Profit loss IFRS (5-year summary) | Prior1YearDuration | -868252000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 676446000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | 1658805000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 388825000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | Prior1QuarterDuration | 325432000 | JPY |
| Profit loss attributable to owners of parent IFRS (5-year summary) | CurrentQuarterDuration | 1661679000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior1YTDDuration | 2334536000 | JPY |
| Comprehensive income IFRS (5-year summary) | CurrentYTDDuration | 4916349000 | JPY |
| Comprehensive income IFRS (5-year summary) | Prior1YearDuration | 187696000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YTDDuration | 3018532000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | CurrentYTDDuration | 2759653000 | JPY |
| Comprehensive income attributable to owners of parent IFRS (5-year summary) | Prior1YearDuration | 1811272000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1QuarterInstant | 22040559000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | CurrentQuarterInstant | 22976347000 | JPY |
| Equity attributable to owners of parent IFRS (5-year summary) | Prior1YearInstant | 20969692000 | JPY |
| Total assets IFRS (5-year summary) | Prior1QuarterInstant | 35266795000 | JPY |
| Total assets IFRS (5-year summary) | CurrentQuarterInstant | 45050897000 | JPY |
| Total assets IFRS (5-year summary) | Prior1YearInstant | 33906981000 | JPY |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 14.25 | |
| Basic earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | 34.93 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 8.19 | |
| Basic earnings loss per share IFRS (5-year summary) | Prior1QuarterDuration | 6.86 | |
| Basic earnings loss per share IFRS (5-year summary) | CurrentQuarterDuration | 34.99 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YTDDuration | 14.18 | |
| Diluted earnings loss per share IFRS (5-year summary) | CurrentYTDDuration | 34.81 | |
| Diluted earnings loss per share IFRS (5-year summary) | Prior1YearDuration | 8.11 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1QuarterInstant | 0.625 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | CurrentQuarterInstant | 0.510 | |
| Ratio of owners equity to gross assets IFRS (5-year summary) | Prior1YearInstant | 0.618 | |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YTDDuration | 389264000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | CurrentYTDDuration | 872378000 | JPY |
| Cash flows from used in operating activities IFRS (5-year summary) | Prior1YearDuration | 393320000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YTDDuration | -1496808000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | CurrentYTDDuration | -2585288000 | JPY |
| Cash flows from used in investing activities IFRS (5-year summary) | Prior1YearDuration | -4116163000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |